Clinical Trials Logo

Vertebrobasilar Insufficiency clinical trials

View clinical trials related to Vertebrobasilar Insufficiency.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT06129721 Completed - Acute Stroke Clinical Trials

Emergent Stenting In Acute Vertebrobasilar Occlusions

ESVO
Start date: December 1, 2020
Phase: N/A
Study type: Interventional

In the acute posterior circulation strokes, the vertebrobasilar occlusions frequently related to worse outcomes than the anterior ones. However, few studies mentioned the benefit and safety of the emergent stenting in the successful recanalization at these complex occlusions. The investigators investigated whether the improvement of clinical outcome was achieved in postprocedural 3-month.

NCT ID: NCT05503212 Completed - Ischemic Stroke Clinical Trials

Best Revascularisation Approach for Posterior Circulation Strokes With Isolated Vertebral Artery Occlusions

BRAVO
Start date: January 1, 2003
Phase:
Study type: Observational

Isolated vertebral artery occlusions (VAO) account for approximately one third of posterior circulation occlusions, but have been given the least attention among posterior circulation strokes. If the two recent ATTENTION and BAOCHE randomized clinical trials have proven the superiority of endovascular thrombectomy (EVT) in basilar artery occlusions, data on the effectiveness and harm of acute revascularization treatment on isolated VAO is scarce. We aim to investigate the impact of acute recanalisation treatments in acute ischemic stroke patients with isolated VAO. In the absence of RCT, observational data with appropriate statistical methods may give indications on benefits and harms of treating neglected stroke situations like acute vertebral occlusion. Results may also lay the basis for prospective studies, such as randomized clinical trials.

NCT ID: NCT03859674 Completed - Clinical trials for Vertebral Artery Stenosis

Firehorus Rapamycin Target Eluting Vertebral Artery Stent System in Clinical Application

Start date: July 17, 2014
Phase: N/A
Study type: Interventional

This clinical trial uses a prospective, multicenter, single-arm, objective performance criteria-design, aiming to evaluate the safety and effectiveness of Firehorus Rapamycin Target Eluting Vertebral Artery Stent System .

NCT ID: NCT03201432 Completed - Ischemic Stroke Clinical Trials

Drug Eluting Stents Versus Bare Metal Stents for Treatment of Symptomatic Extracranial Vertebral Artery Stenosis

Start date: May 2014
Phase: Phase 2/Phase 3
Study type: Interventional

Stroke is one of the important causes of disability and death in the world, in which more than half were ischemic strokes. About 1/4 of the ischemic stroke occurred in the vertebral basilar artery system, especially when in the presence of extracranial proximal vertebral artery stenosis. Vertebral artery stenting is a minimally invasive method for the reconstruction of vertebral artery stenosis and the early clinical studies showed that it was feasible, safe and effective, but the high rate of restenosis has become a bottleneck restricting its development. Previous systematic review had suggested that the drug eluting stent might reduce the incidence of restenosis of vertebral artery. However, prospective randomized controlled trials comparing the efficacy of bare metal stents and drug eluting stents on the prevention of restenosis remains absent.

NCT ID: NCT02991976 Completed - Clinical trials for Hypoxia-Ischemia, Brain

Oxygen Concentration and Recovery After Carotid Endarterectomy

Start date: November 2016
Phase: N/A
Study type: Interventional

This study evaluates effects of high inspiratory oxygen on cerebral tissue oxygenation and patient recovery after carotid endarterectomy. Two group of patient undergoing to carotid with total intravenous anaesthesia will receive either 35% inspired oxygen or 100% oxygen.

NCT ID: NCT02328781 Completed - Clinical trials for Vertebrobasilar Insufficiency

Prospective Evaluation of Safety and Efficacy Vertebral Drug-eluting Stent System

PESS
Start date: July 17, 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of Firehorus vertebral artery rapamycin-target-eluting stent system (hereinafter referred to as Firehorus) in treatment of symptomatic vertebral artery stenosis.

NCT ID: NCT00590980 Completed - Stroke Clinical Trials

Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS)

VERiTAS
Start date: July 2008
Phase: N/A
Study type: Observational

Patients with blockage of the blood vessels that supply blood to the back of the brain, known as vertebrobasilar disease (VBD), are at risk of having a stroke or temporary symptoms of a stroke known as transient ischemic attack (TIA). The risk of repeated stroke associated with VBD may be affected by several risk factors, including the degree to which the blockage reduces the blood flow to the brain. Patients with VBD have different levels of blockage ranging from partial blockage to complete blockage, which can affect the blood flow to the brain by variable amounts. The purpose of this research is to determine if patients with symptomatic VBD who demonstrate low blood flow to the back of the brain on magnetic resonance (MR)imaging are at higher risk of developing another stroke or TIA than patients with normal blood flow.